S&T Partners with PNNL to Improve Capabilities of Portable Drug Detection Systems
DHS S&T is working with vendors and manufacturers of portable drug detectors to improve their ability to identify different narcotics, like fentanyl.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock
()
or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
DHS S&T is working with vendors and manufacturers of portable drug detectors to improve their ability to identify different narcotics, like fentanyl.
Canada and the United States have an enduring partnership guided by a shared commitment to security, prosperity, and advancing democratic values.
DHS issued an update on Operation Blue Lotus as part of the Biden Administration’s significant and historic actions to disrupt the trafficking of synthetic drugs, representing a major contribution to a government-wide effort to save lives and pursue justice and accountability.
DHS announced that Operation Blue Lotus, a new coordinated and surge operation targeting the smuggling of fentanyl, stopped more than 900 pounds of fentanyl from coming into the United States in its first week.
The DHS Science and Technology Directorate's (S&T) Opioid Trafficking Intelligence and Investigation Project provides research and development (R&D) support for improved investigative capabilities to aid in the confident discovery, identification, and disruption of illicit drug networks responsible for opioid smuggling. The project will include training on investigative processes for law enforcement partners and advanced analytic approaches to facilitate analysis of evidence, data fusion, and information sharing that enables automated discovery of high value targets and criminal associations. Project outputs will be integrated into HSI's existing suite of investigative capabilities, to support
prosecution as well as collaboration efforts in furtherance of interdiction and disruption of the opioid supply chain.
The DHS Science and Technology Directorate’s (S&T) Opioid/Fentanyl Detection Program, in collaboration with the S&T Office of Standards, is funding the Pacific Northwest National Laboratory (PNNL) to build spectral reference libraries of approximately 50 Drug Enforcement Administration (DEA) restricted substances. including fentanyl, fentanyl analogues, and other emerging illicit drugs. Through Cooperative Research and Development Agreements (CRADAs) with industry partners, PNNL will collect reference spectra on 20 different field portable detectors currently deployed for operational use.
The DHS Science and Technology Directorate’s (S&T) Opioid Program is working with HSI and Sandia National Laboratories (SNL) to develop novel software applications that can be integrated with HSI’s Repository for Analytics in a Virtualized Environment (RAVEN) platform. This cloud-based platform enables users to perform analytics across datasets using a suite of search, analytical, and reporting tools. RAVEN serves as a central point to gather and conduct analyses across seemingly disparate datasets, replacing a largely manual process. This collaborative effort will apply advanced analytical approaches, like artificial intelligence and machine learning, to better recognize patterns in data and enhance investigators’ effectiveness.
DHS S&T has released a new Master Question List (MQL) for Synthetic Opioids.
S&T's Master Question List for Synthetic Opioids consolidates information and knowledge gaps to better focus investments on the most useful R&D.
The newly published standards will be put into effect almost immediately through a S&T-led research and development effort with PNNL.